Cellebrite DI Ltd.
CLBT
$15.67
-$0.33-2.06%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 109.05M | 95.71M | 89.58M | 93.01M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 109.05M | 95.71M | 89.58M | 93.01M | |
| Cost of Revenue | 17.62M | 16.26M | 13.26M | 14.92M | |
| Gross Profit | 91.43M | 79.45M | 76.32M | 78.10M | |
| SG&A Expenses | 50.10M | 43.27M | 43.87M | 41.35M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 93.32M | 83.23M | 80.34M | 78.01M | |
| Operating Income | 15.73M | 12.49M | 9.25M | 15.00M | |
| Income Before Tax | 19.90M | -22.02M | -69.33M | -12.35M | |
| Income Tax Expenses | 628.00K | 1.80M | 2.04M | 2.30M | |
| Earnings from Continuing Operations | 19.27M | -23.81M | -71.37M | -14.65M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 19.27M | -23.81M | -71.37M | -14.65M | |
| EBIT | 15.73M | 12.49M | 9.25M | 15.00M | |
| EBITDA | 18.46M | 15.06M | 11.93M | 17.61M | |
| EPS Basic | 0.08 | -0.12 | -0.36 | -0.08 | |
| Normalized Basic EPS | 0.05 | -0.07 | -- | -0.04 | |
| EPS Diluted | 0.08 | -0.12 | -0.36 | -0.08 | |
| Normalized Diluted EPS | 0.05 | -0.07 | -- | -0.04 | |
| Average Basic Shares Outstanding | 233.25M | 198.95M | 196.82M | 194.44M | |
| Average Diluted Shares Outstanding | 247.35M | 198.95M | 196.82M | 194.44M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |